Thus, in future studies, a larger cohort and in vivo experiments should be conducted to further elucidate the underlying mechanism associated with lncRNA ROR, MLL1, H3K4 methylation and TIMP3 in breast cancer. Here, KMT2A is linked to breast carcinoma.